§ Funding Round
Octant Bio raised $80M Series B venture round, led by diamantis xylas.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Andreessen Horowitz | — | — |
Bristol Myers Squibb | — | — |
diamantis xylasLEAD | Angel | diamantis xylas |
Fifty Years | — | — |
| Organization | — | |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Kleiner Perkins | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | Balaji Srinivasan |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$115M
Top Valuation
-
Octant Bio raised $80M in a Series B round.
The round was announced on 04/21/22.
The round was led by diamantis xylas.
